semaglutide heart Study Finds Oral Vastly Reduces Attacks, Strokes Semaglutide Cuts Heart Risk Beyond

Richard brings incredible passion and drive for the science, and his confidence rubs off and inspires those working with him. Archita Agrawal, one of DiMarchis last graduate students, currently conducts research on finding hidden peptides in the human genome with the Salk Institute for Biological Studies Alan Saghatelian

GLP-1s are still relevant to the growth narrative: management disclosed $230M (39%) in Q1 2025 and $190M (35%) in Q2 2025

Following a gradual dosing schedule helps your body adapt to the medication, which significantly reduces your risk of side effects

GLP-1 is an incretin hormone that enhances glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying, improving glycemic control and promoting weight loss

This could be a sign of body recomposition where fat is replaced with muscle

GLP-1 is an incretin hormone that is secreted from the intestine postprandial via the incretin effect